ARK Genomic Revolution ETF (ARKG) |
| 29.3 1.4 (5.02%) 04-14 16:00 |
| Open: | 28.3 |
| High: | 29.545 |
| Low: | 28.3 |
| Volume: | 3,543,322 |
| Market Cap: | 1,182(M) |
| PE Ratio: | 0 |
| Exchange: | Chicago Board Options Exchange |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 34.51 |
| Resistance 1: | 29.55 |
| Pivot price: | 26.93 |
| Support 1: | 26.49 |
| Support 2: | 24.60 |
| 52w High: | 34.39 |
| 52w Low: | 20.21 |
ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors that are relevant to the Fund’s investment theme of the genomics revolution.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Mon, 13 Apr 2026
Technical Reactions to ARKG Trends in Macro Strategies - Stock Traders Daily
Thu, 02 Apr 2026
Trading the Move, Not the Narrative: (ARKG) Edition - Stock Traders Daily
Thu, 05 Mar 2026
ARK Invest Funds: Best Long-Term Growth Potential Through 2026 Analysis - Bitget
Thu, 05 Mar 2026
ARK ETF Comparison Guide: ARKK, ARKG, ARKQ & ARKF for Long-Term Growth - Bitget
Wed, 28 Jan 2026
ARKG: Cathie Wood's Biotech Product Is In Rally Mode (BATS:ARKG) - Seeking Alpha
Thu, 22 Jan 2026
ARKG Forecast — Price Prediction for 2026. Should I Buy ARKG? - Intellectia AI
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
